Release Date: 30/08/18 08:53 Summary: 2018 Half Year Financial Report Price Sensitive: Yes Download Document 429.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%